Read Time:10 Second
Generic-drug maker Sandoz Group was valued at around 10.3 billion Swiss francs ($11.18 billion) in its trading debut on the SIX Swiss Exchange after it was spun off from Novartis.
Happy
0 %
Sad
0 %
Excited
0 %
Sleepy
0 %
Angry
0 %
Surprise
0 %
0
0
